Research from the field of heart medicine. Covers light exposure and heart health, lifestyle and longevity, and regional cardiology care.
NewYork-Presbyterian/Weill Cornell Medical Center has been recognized as a mitral valve repair reference center by the Mitral Foundation for three consecutive years. The award highlights the institution's commitment to delivering high-quality care and advancing best practices in surgical treatment of mitral valve disease.
A study led by Lancaster University found that social and environmental factors impact a patient's physical readiness for surgery. Patients from socioeconomically deprived areas tend to have lower cardiorespiratory fitness, which can lead to poorer surgical outcomes.
The American Heart Association (AHA) and the American College of Cardiology (ACC) have published a new set of clinical practice guidelines for left atrial appendage occlusion (LAAO) to guide stroke prevention in non-valvular atrial fibrillation (NVAF) patients. The guidelines provide specific recommendations for clinicians, patients, a...
A study of 1,081 elderly patients with AFMR found that TEER minimally invasive valve repair significantly lowered mortality and hospitalization rates compared to standard medical therapy alone. The procedure's success was also linked to the degree of residual mitral regurgitation after surgery.
A study in the Canadian Journal of Cardiology finds that delaying chest compressions to prevent tongue swallowing can lead to poor outcomes, including death or severe brain injury. The research exposes media-fueled misconceptions and emphasizes the importance of immediate CPR training.
A new online tool calculates a person's 'heart age' based on cardiovascular disease risk factors, revealing significant gaps among certain groups. On average, women had a heart age of 55.4, while men had an average heart age of 56.7, with disparities found among those with lower incomes or education.
A coordinated approach is needed to address the scientific value of trial representation of the intended use population. The study aims to provide a strategic framework to ensure scientific validity by operationalizing broad representation at all levels.
At ESC Congress 2025, over 40 pivotal studies will be presented, addressing major clinical questions and unmet needs in global cardiovascular care. The trials focus on innovative treatments for conditions like chronic Chagas cardiomyopathy and hypertrophic cardiomyopathy.
The Mount Sinai Hospital has been listed among the nation's top 20 hospitals for care excellence by U.S. News & World Report for 2025-26, with top-10 rankings in five specialties and top-20 rankings in nine. The hospital was also rated High Performing in all 22 procedures and conditions assessed by U.S. News.
Researchers from FAU's Schmidt College of Medicine recommend using high-potency statins as the primary pharmacologic approach in treating and preventing cardiovascular disease. Lifestyle changes, such as regular physical activity and a healthy diet, are also crucial in reducing cardiovascular risk.
The 250,000-square-foot facility provides greater availability to high-quality integrated care, addressing the region's increasing demand for innovative diagnostic and treatment services. The pavilion brings together a broad range of nationally ranked clinical programs, including cancer clinics, neurology, and surgery.
This study found that moderate to vigorous-intensity physical activity declined from early adulthood to midlife, with notable demographic differences. Black women experienced the lowest physical activity across adulthood and highest risk of low physical activity post-CVD.
A large clinical study found that high-tech oxygen level monitoring during heart surgery did not lower the risk of serious complications afterward. Fewer pneumonia cases were reported in patients with advanced monitoring, but this difference may have been coincidental.
Research warns that GLP-1 drugs may not provide the long-term health benefit of improved heart and lung function. While they help with weight loss, patients may experience significant muscle loss, which can increase cardiovascular disease risk. Doctors are urging additional research to better understand the effects of these drugs.
Delays in hypertension diagnosis were common, associated with delayed treatment initiation and adverse cardiovascular outcomes. The study highlights the need for earlier identification and intervention to improve treatment and patient outcomes.
A study of over 7,600 Brazilian women found that early menarche increases risk for metabolic and heart problems, while late menarche may protect against obesity but increase certain heart issues. Understanding age at first period can help doctors identify high-risk patients and guide personalized screening and prevention efforts.
Researchers developed a new diagnostic method using Doppler ultrasound waveform to estimate toe brachial index (TBI), providing faster and more accurate results for early detection of peripheral artery disease (PAD). The study found eTBI to be consistent with standard TBI, detecting effectiveness of treatments in improving blood flow.
Researchers developed an AI model that screens for cardiac amyloidosis with high accuracy, outperforming existing methods. The tool analyzes routine heart ultrasound images to quickly detect the condition and differentiate it from other heart issues.
Researchers highlight a significant gap in detecting symptoms and preventive measures before myocardial infarctions, with distinct differences found between age groups and genders.
Researchers at University of Liège developed a safer, more environmentally friendly polymer called PHOx, which outperforms traditional polyurethane in critical medical applications. PHOx reduces blood clotting risks, inhibits bacterial adhesion, and is biocompatible, making it suitable for custom-made implants.
The Society for Cardiovascular Angiography and Interventions (SCAI) has published evidence-based clinical practice guidelines for the management of chronic venous disease. The guidelines provide patient-centered recommendations on therapeutic options, including compression therapy, wound care, and minimally invasive procedures. Key fin...
A new ESC Clinical Consensus Statement highlights vaccination as a crucial preventive strategy for reducing cardiovascular events following viral and bacterial infections. Vaccines are recommended for patients with chronic coronary syndromes and heart failure, particularly those at increased risk due to underlying medical conditions.
Academic medical centers can transform patient care by adopting learning health system principles, harnessing real-time data analysis and AI to improve patient outcomes. The proposed model aims to establish a smarter, more efficient and equitable care model by integrating diverse databases and leveraging AI for personalized, proactive ...
A decrease in acute myocardial infarction deaths has led to an increase in deaths from other types of chronic heart conditions. The researchers attribute this shift to improved management and prevention of heart attacks, resulting in more patients living beyond these events and developing other heart conditions.
A study published in JACC found that long-term exposure to wildfire smoke may increase the risk of heart failure, particularly among older adults, women, and those living in lower-income areas. The risk was found to be higher with increased levels of PM2.5 air pollution from wildfires compared to other types of air pollution.
Cancer patients treated with immune checkpoint inhibitors are at risk of heart damage due to rapid loss of protective immune cells. Researchers found a biomarker, CD69, can predict which patients are most at risk and may help doctors monitor them more closely.
A study found that specific bacteria in breast cancer patients' gut microbiomes correlate with heart health biomarkers, suggesting they are at greater risk of heart damage during chemotherapy. Researchers hope tailored probiotics could play a role in protecting patients against the harmful effects of cancer treatment.
JMIR Publications' portfolio of journals now includes 21 titles with a Journal Impact Factor. Several journals saw significant increases in impact factor, including JMIR Medical Education, which debuted with a score of 12.5, securing the top-ranked journal spot in its category.
The BMJ finds serious misreporting in two key platelet studies used to gain FDA approval for ticagrelor, a multibillion-dollar heart drug. The investigation reveals inaccurate primary endpoint results and unreported data, casting fresh doubts on the drug's safety and effectiveness.
The collaboration aims to co-develop new treatment paradigms and accelerate innovation in cardiac care, with a focus on Asian populations. The partnership will create opportunities for breakthrough research, knowledge exchange, and training for healthcare professionals.
The Journal EuroIntervention has recorded an impressive Impact Factor of 9.5, making it one of the most cited publications in interventional cardiology. This achievement is attributed to the journal's commitment to publishing high-quality clinical articles and expert commentaries.
PerDeCT is a device designed to monitor cardiac patients after surgery and provide early diagnosis of cardiac tamponade. The device aims to balance the benefit and risk of using devices to monitor cardiac output and detect tamponade easily, before damage is done.
The new program offers minimally invasive treatments for cardiovascular issues, including transcatheter aortic valve replacement and left atrial appendage occlusion. The cardiac catheterization lab features state-of-the-art equipment, allowing improved diagnostic imaging and safer procedures.
Researchers at Stanford Medicine successfully grew heart and liver organoids with integrated blood vessels, allowing them to overcome the current size limit. These vascularized organoids can grow larger and reach a more mature state, making them more useful as biological models for research and potential treatment of various diseases.
The ACC Care of the Athletic Heart conference equips cardiovascular care teams with tools to succeed in sports cardiology. The event covers core sports cardiology tools and case-based learning for competitive and tactical athletes.
A novel screening approach called VEST uses virtual echocardiography to identify patients at high risk of pulmonary arterial hypertension, a life-threatening form of heart failure. The tool has been shown to generate accurate PAH risk scores without manual calculations and can guide timely referrals for expert care.
The Association of Cardiovascular Nursing and Allied Professions (ACNAP) will host its annual congress from 12 to 14 June 2025 in Sophia Antipolis, France. Nurses and allied health professionals will share knowledge and network to drive real change in cardiovascular care.
A recent study found that nearly 1 in 6 adults with hypertension and 3 in 10 with diabetes were unaware of their condition by 2021-2023. Young adults and women are disproportionately affected by a lack of awareness.
A cohort study of schools found that COVID-19-related decline in youth physical fitness persisted during the pandemic, but not associated with remote or hybrid environments. The reduction was observed in cardiorespiratory and musculoskeletal fitness healthy zone achievement.
A new study reveals that combining heart valve replacement with specific drug therapy offers significant survival benefits for patients with severe aortic stenosis and cardiac amyloidosis. The treatment significantly lowers the risk of death in both forms of treatment, especially when combined.
Research led by Amsterdam UMC reveals the hearts of female elite athletes have different characteristics compared to their male counterparts. Female athletes exhibit dilation of the heart chambers, whereas males show thickening in combination with a dilation of the heart muscle. This finding can aid doctors in identifying possible hear...
A cross-sectional study found a strong association between chronic cannabis use and endothelial dysfunction. The findings suggest that THC may contribute to the development of cardiovascular disease through distinct mechanisms, similar to tobacco smoking.
The university successfully secured funding for two new clusters, SCALE and CPI, which will focus on understanding cellular architecture and cardiovascular diseases. The clusters aim to pioneer new paths in medicine through innovative research.
The study analyzed 14.7 million excess US deaths from 1980 to 2023, finding that rates remained higher than pre-pandemic levels. Excess deaths during and after the pandemic were largely driven by pre-existing causes such as drug overdose, firearm injury, and cardiometabolic disease.
A study found that prescribing guideline-directed medical treatment to patients 90 years and older following their first heart attack can improve survival rates. The greatest benefit was observed in those who received all four recommended therapies, including beta-blockers and renin-angiotensin-aldosterone system inhibitors.
A new smartphone app, ECHAS, can help people determine if they are suffering from a heart attack or stroke and need medical attention. The app, developed by experts at UVA Health and other leading institutions, proved effective in identifying patients with cardiac and neurological emergencies.
The 4D-ACS trial showed a 49% reduction in net adverse clinical events and a 77% decrease in bleeding events with one-month DAPT followed by prasugrel 5mg monotherapy, demonstrating enhanced safety without compromising ischaemic protection for East Asian ACS patients.
A meta-analysis of PROTECTED TAVR and BHF PROTECT-TAVI trials reveals no significant difference between control arms with and without cerebral embolic protection devices during TAVI. This conclusion challenges the use of CEP devices in TAVI procedures.
The FAITAVI trial found that FFR-guided PCI reduced major adverse cardiac and cerebrovascular events at 12-month follow-up in patients with intermediate coronary artery disease undergoing TAVI. FFR-guided PCI was associated with lower rates of all-cause death and ischaemia-driven target vessel revascularisation.
Professor Lars Wallentin and Professor Stefan James will receive the award on behalf of a wider team of Swedish cardiovascular registry experts who have advanced cardiovascular medicine through SWEDEHEART and SCAAR registries. The award recognises their contributions to improving patient care in Sweden and globally.
The RESIL-Card project is piloting its resilience assessment tool in selected European countries to evaluate its effectiveness, usability, and relevance for healthcare professionals. The tool provides structured guidance for assessing and improving the resilience of cardiovascular care pathways.
The National Heart Centre Singapore is launching a nationwide AI initiative to reduce hours of specialist analysis for cardiac scans from minutes, aiding early detection and prediction of coronary artery disease. The SENSE project will apply advanced machine learning technology to interpret cardiac imaging scans.
Surgeons at Mount Sinai performed the world's first heart-liver-kidney triple organ transplants in New York State, with two patients making full recoveries after the surgeries. The procedures were led by Anelechi Anyanwu and Sander S. Florman and represent a significant milestone in complex organ transplantation.
A study published in the European Heart Journal found that male bodybuilders have a high risk of sudden cardiac death, with professional bodybuilders facing a more than fivefold increase in risk. The study highlights the need for greater awareness, preventive strategies and policy changes within the bodybuilding community.
Researchers identified a biological process causing donor heart damage during cold storage and found that a drug can prevent this damage. Treatment with the drug nearly tripled pumping strength in human donor hearts, improving blood flow and reducing cell injury.
Two out of five heart failure patients do not see a cardiologist annually, significantly increasing mortality risk. Patients who receive regular cardiology care are 24% less likely to die in the following year, with optimal visits ranging from once to four times per year depending on recent hospitalization and diuretic use.
A study of 1,792 participants found that a higher waist-to-height ratio was associated with an increased risk of heart failure. The research suggests that waist-to-height ratio may be a better metric than BMI to identify patients who could benefit from therapies for obesity.
A pharmaceutically produced cannabidiol formulation demonstrated a good overall safety profile, including cardiac safety, in patients at increased cardiovascular risk. The trial found low rates of cardiac side effects, with one patient experiencing mild QTc prolongation detected by electrocardiogram.
Researchers created over 3,800 anatomically accurate digital hearts to investigate how age, sex, and lifestyle affect heart disease. They found that age and obesity cause changes in the heart's electrical properties, which could explain why these factors are linked to a higher risk of heart disease.
A nationwide cohort study found that immune checkpoint inhibitors significantly increase the risk of myocarditis in NSCLC patients, with a 7.4-fold increase in risk compared to non-users. Cardiac monitoring for at least six months following ICI initiation is recommended.